SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001558370-19-010629
Filing Date
2019-11-08
Accepted
2019-11-08 17:19:33
Documents
8
Period of Report
2019-11-08

Document Format Files

Seq Description Document Type Size
1 PRE 14A pre14a.htm PRE 14A 962223
3 GRAPHIC coverg001.jpg GRAPHIC 20191
4 GRAPHIC pre14ag001.jpg GRAPHIC 88851
5 GRAPHIC pre14ag002.jpg GRAPHIC 4250
6 GRAPHIC pre14ag003.gif GRAPHIC 117466
7 GRAPHIC pre14ag004.gif GRAPHIC 84879
8 GRAPHIC pre14ag005.gif GRAPHIC 109505
9 GRAPHIC pre14ag006.gif GRAPHIC 105877
  Complete submission text file 0001558370-19-010629.txt   1695524
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37350 | Film No.: 191205028
SIC: 3841 Surgical & Medical Instruments & Apparatus